• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内动脉瘤修复术中通路并发症的长期影响。

The long-term implications of access complications during endovascular aneurysm repair.

机构信息

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass; Division of Cardiac, Thoracic, and Vascular Surgery, New York-Presbyterian/Columbia University Irving Medical Center, Columbia University Vagelos College of Physicians & Surgeons, New York, NY.

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins Hospital, Baltimore, Md.

出版信息

J Vasc Surg. 2021 Apr;73(4):1253-1260. doi: 10.1016/j.jvs.2020.08.033. Epub 2020 Sep 1.

DOI:10.1016/j.jvs.2020.08.033
PMID:32889076
Abstract

BACKGROUND

Access issues are one of the most common complications of endovascular aneurysm repair (EVAR). However, contemporary rates as well as risk factors for complications and the subsequent impact of access complications on mortality are poorly described.

METHODS

We studied all EVAR for intact abdominal aortic aneurysms without prior aortic surgery in the Vascular Quality Initiative between 2011 and 2018. We studied factors associated with access complications (thrombosis, embolus, wound infection, hematoma, and conversion to cutdown), as well as the interaction with female sex and the impact on survival using multilevel logistic regression and propensity weighting. Multiple imputation was used for missing data.

RESULTS

There were 33,951 EVAR during the study period (91% elective, 9% symptomatic); most cases (70%) involved an attempt at percutaneous access on at least one side, with 30% bilateral cutdowns and 0.1% iliac conduits. There were 1553 patients (4.6%) who experienced at least one access complication. Access complications were almost twice as common in female patients (7.5% vs 3.9%; P < .001). The factors associated with access complications included female sex (odds ratio [OR], 2.7; 95% confidence interval [CI], 2.0-3.6; P < .001), age (OR, 1.05 per 5 years; 95% CI, 1.02-1.1; P < .01), aortouni-iliac device (OR, 1.6; 95% CI, 1.1-2.3; P < .01), smoking (OR, 1.4; 95% CI, 1.1-1.7; P < .01), body mass index of less than 16 (OR, 1.8; 95% CI, 1.3-2.5; P = .001), dual antiplatelet therapy (1.3; 95% CI, 1.02-1.6 P = .03), prior infrainguinal bypass (OR, 1.8; 95% CI, 1.3-2.7; P < .01), and beta blocker use (OR, 1.2; 95% CI, 1.03-1.4; P = .02). Conversion from percutaneous access to open cutdown was associated with higher rates of complications than planned open cutdown (8.6% vs 2.9%; P < .001). In propensity-weighted analysis, percutaneous access was associated with significantly lower odds of access complications in women (OR, 0.6; 95% CI, 0.4-0.96; P = .03). Patients who experienced an access complication had more than four times the odds of perioperative death (OR, 4.2; 95% CI, 2.5-7.1; P < .001), and a 60% higher risk of long-term mortality (hazard ratio, 1.6; 95% CI, 1.2-2.1; P = .001). In addition to death, patients with access site complications had higher rates of other major complications, including reoperation during the index hospitalization (19% vs 1.2%; P < .001), myocardial infarction (3.5% vs 0.7%; P < .001), stroke (0.8% vs 0.2%; P < .001), acute kidney injury (12% vs 3%; P < .001), and reintubation (5.7% vs 0.8%).

CONCLUSIONS

Although access complications are infrequent in the current era, they are associated with both perioperative and long-term morbidity and mortality. Female patients in particular are at high risk of access complications, but may benefit from percutaneous access.

摘要

背景

血管腔内动脉瘤修复术(EVAR)的最常见并发症之一是通路问题。然而,目前并发症的发生率以及危险因素,以及随后的通路并发症对死亡率的影响,都描述得很差。

方法

我们研究了 2011 年至 2018 年期间血管质量倡议中所有未经主动脉手术的完整腹主动脉瘤的 EVAR。我们研究了与通路并发症(血栓形成、栓塞、伤口感染、血肿和转为切开术)相关的因素,以及女性性别与这些并发症的相互作用,以及使用多级逻辑回归和倾向评分加权对生存率的影响。使用多重插补法处理缺失数据。

结果

研究期间共进行了 33951 例 EVAR(91%为择期手术,9%为症状性);大多数病例(70%)至少在一侧尝试了经皮入路,其中 30%为双侧切开术,0.1%为髂骨导管。有 1553 名患者(4.6%)至少经历了一次通路并发症。女性患者的通路并发症几乎是男性的两倍(7.5%比 3.9%;P<0.001)。与通路并发症相关的因素包括女性性别(比值比[OR],2.7;95%置信区间[CI],2.0-3.6;P<0.001)、年龄(每增加 5 岁 OR 增加 1.05;95%CI,1.02-1.1;P<0.01)、腹主动脉-髂动脉装置(OR,1.6;95%CI,1.1-2.3;P<0.01)、吸烟(OR,1.4;95%CI,1.1-1.7;P<0.01)、体重指数低于 16(OR,1.8;95%CI,1.3-2.5;P=0.001)、双联抗血小板治疗(1.3;95%CI,1.02-1.6;P=0.03)、先前的下肢旁路术(OR,1.8;95%CI,1.3-2.7;P<0.01)和β受体阻滞剂的使用(OR,1.2;95%CI,1.03-1.4;P=0.02)。从经皮入路转为开放切开术与计划的开放切开术相比,并发症发生率更高(8.6%比 2.9%;P<0.001)。在倾向评分加权分析中,女性经皮入路与通路并发症的几率显著降低(OR,0.6;95%CI,0.4-0.96;P=0.03)。经历过通路并发症的患者在围手术期死亡的几率是其他患者的四倍以上(OR,4.2;95%CI,2.5-7.1;P<0.001),长期死亡率的风险增加 60%(风险比,1.6;95%CI,1.2-2.1;P=0.001)。除了死亡,有通路部位并发症的患者其他主要并发症的发生率也较高,包括住院期间再次手术(19%比 1.2%;P<0.001)、心肌梗死(3.5%比 0.7%;P<0.001)、中风(0.8%比 0.2%;P<0.001)、急性肾损伤(12%比 3%;P<0.001)和再插管(5.7%比 0.8%)。

结论

尽管目前通路并发症并不常见,但它们与围手术期和长期的发病率和死亡率都有联系。特别是女性患者,通路并发症的风险很高,但可能受益于经皮入路。

相似文献

1
The long-term implications of access complications during endovascular aneurysm repair.血管内动脉瘤修复术中通路并发症的长期影响。
J Vasc Surg. 2021 Apr;73(4):1253-1260. doi: 10.1016/j.jvs.2020.08.033. Epub 2020 Sep 1.
2
The state of complex endovascular abdominal aortic aneurysm repairs in the Vascular Quality Initiative.血管质量倡议中的复杂内脏腹主动脉瘤修复状态。
J Vasc Surg. 2019 Aug;70(2):369-380. doi: 10.1016/j.jvs.2018.11.021. Epub 2019 Feb 2.
3
Contemporary outcomes of endovascular abdominal aortic aneurysm repair in patients deemed unfit for open surgical repair.血管内腹主动脉瘤修复术在被认为不适合开放手术修复的患者中的当代结果。
J Vasc Surg. 2021 May;73(5):1583-1592.e2. doi: 10.1016/j.jvs.2020.08.147. Epub 2020 Oct 6.
4
Fenestrated endovascular aneurysm repair is associated with lower perioperative morbidity and mortality compared with open repair for complex abdominal aortic aneurysms.与开放修复相比,开窗型血管内动脉瘤修复与复杂腹主动脉瘤围手术期较低的发病率和死亡率相关。
J Vasc Surg. 2019 Jun;69(6):1670-1678. doi: 10.1016/j.jvs.2018.08.192. Epub 2018 Dec 13.
5
Comparison of access type on perioperative outcomes after endovascular aortic aneurysm repair.血管内主动脉瘤修复术后围手术期结局的入路类型比较。
J Vasc Surg. 2018 Jul;68(1):91-99. doi: 10.1016/j.jvs.2017.10.075. Epub 2018 Jan 17.
6
Comparable perioperative mortality outcomes in younger patients undergoing elective open and endovascular abdominal aortic aneurysm repair.在接受择期开放和血管内腹主动脉瘤修复的年轻患者中,围手术期死亡率结果相当。
J Vasc Surg. 2018 May;67(5):1404-1409.e2. doi: 10.1016/j.jvs.2017.08.057. Epub 2017 Oct 31.
7
Percutaneous versus femoral cutdown access for endovascular aneurysm repair.经皮穿刺与股动脉切开入路用于血管内动脉瘤修复术
J Vasc Surg. 2015 Jul;62(1):16-21. doi: 10.1016/j.jvs.2015.01.058. Epub 2015 Mar 28.
8
Defining risk and identifying predictors of mortality for open conversion after endovascular aortic aneurysm repair.定义血管腔内主动脉瘤修复术后开放转换的风险并确定死亡预测因素。
J Vasc Surg. 2016 Apr;63(4):873-81.e1. doi: 10.1016/j.jvs.2015.09.058. Epub 2015 Nov 21.
9
Non-guideline-compliant endovascular abdominal aortic aneurysm repair in women is associated with increased mortality and reintervention compared with men.与男性相比,女性非符合指南的血管腔内腹主动脉瘤修复术与死亡率增加和再次干预相关。
J Vasc Surg. 2022 Jan;75(1):118-125.e1. doi: 10.1016/j.jvs.2021.07.109. Epub 2021 Jul 22.
10
Anemia and postoperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms.非破裂性腹主动脉瘤开放修复和血管内修复术后贫血与结局的关系。
J Vasc Surg. 2019 Mar;69(3):738-751.e2. doi: 10.1016/j.jvs.2018.05.233. Epub 2019 Jan 23.

引用本文的文献

1
Prospective evaluation of automated vascular analysis for ilio-femoral artery lesions before and after percutaneous endovascular aortic repair.前瞻性评估血管自动分析在经皮腔内血管修复术前后髂股动脉病变中的应用。
J Cardiothorac Surg. 2024 Aug 28;19(1):497. doi: 10.1186/s13019-024-03013-1.
2
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices.经大口径器械行股动脉入路患者中减少入路相关并发症的策略。
Curr Vasc Pharmacol. 2024;22(2):79-87. doi: 10.2174/0115701611233184231206100222.
3
Percutaneous Approach in Endovascular Aortic Procedures Using a Suture-Mediated Closure Device.
使用缝线介导闭合装置的血管内主动脉手术中的经皮入路
J Clin Med. 2022 Nov 10;11(22):6660. doi: 10.3390/jcm11226660.